Connor, Clark & Lunn Investment Management Ltd. Care Dx, Inc. Transaction History
Connor, Clark & Lunn Investment Management Ltd.
- $26 Billion
- Q2 2025
A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Care Dx, Inc. stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 1,082,308 shares of CDNA stock, worth $16.5 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
1,082,308
Previous 1,003,580
7.84%
Holding current value
$16.5 Million
Previous $17.8 Million
18.72%
% of portfolio
0.08%
Previous 0.08%
Shares
17 transactions
Others Institutions Holding CDNA
# of Institutions
211Shares Held
55.5MCall Options Held
85KPut Options Held
33.1K-
Black Rock Inc. New York, NY5.29MShares$80.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.91MShares$74.7 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA2.54MShares$38.7 Million0.01% of portfolio
-
Bamco Inc New York, NY2.44MShares$37.1 Million0.14% of portfolio
-
State Street Corp Boston, MA2.18MShares$33.2 Million0.0% of portfolio
About CareDx, Inc.
- Ticker CDNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 53,458,100
- Market Cap $814M
- Description
- CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...